NEOG vs NTLA: stock comparison and AI forecast
Neogen Corp (NEOG) and Intellia Therapeutics, Inc. (NTLA) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
NEOG Neogen Corp
- Market Cap
- $2.58B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
NTLA Intellia Therapeutics, Inc.
- Market Cap
- $1.75B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
- NO CURRENT FORECAST
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- NEOG is 1.5 times larger than NTLA by market capitalization ($2.58B against $1.75B).
- NEOG turns -5.8% of its revenue into net income, against -672.2% for NTLA.
- NEOG carries 0.58 times debt per unit of equity, against 0.18 times for NTLA.
- Both companies share the SEC industry classification In Vitro & In Vivo Diagnostic Substances.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | NEOG | NTLA |
|---|---|---|
| Market Cap | $2.58B | $1.75B |
| P/B Ratio | 1.24x | 2.40x |
| EPS | $-0.26 | $-2.53 |
| Book Value/Share | $9.56 | $5.19 |
| Revenue/Share | $4.05 | $0.42 |
| FCF/Share | $0.23 | $-2.49 |
Profitability & Margins
| Metric | NEOG | NTLA |
|---|---|---|
| ROE | -2.5% | -55.0% |
| ROA | -1.6% | -46.7% |
| ROIC | -0.2% | -54.5% |
| Gross Margin | 47.4% | – |
| Operating Margin | -0.8% | -711.7% |
| Net Margin | -5.8% | -672.2% |
| EBT Margin | -7.7% | -711.7% |
| Tax Rate | 17.1% | – |
Financial Health
| Metric | NEOG | NTLA |
|---|---|---|
| Current Ratio | 3.90x | 6.65x |
| Quick Ratio | 2.92x | – |
| D/E Ratio | 0.58x | 0.18x |
| Financial Leverage | 1.58x | 1.18x |
| Interest Coverage | -0.1x | – |
| Working Capital | $433M | $448M |
Cash Flow
| Metric | NEOG | NTLA |
|---|---|---|
| Operating Cash Flow | $85M | -$347M |
| Free Cash Flow | $50M | -$349M |
| Capital Spending | -$36M | -$2M |
| OCF Growth YoY | -2.0% | – |
| FCF/Sales | 5.6% | -586.0% |
| CapEx/Sales | 4.0% | 3.4% |
Operational Efficiency
| Metric | NEOG | NTLA |
|---|---|---|
| Asset Turnover | 0.27x | 0.07x |
| Receivables Turnover | 6.5x | 8.1x |
| Inventory Turnover | 3.2x | – |
| Fixed Assets Turnover | 2.7x | 4.0x |
| Days Sales Outstanding | 56 days | 45 days |
| Days Inventory | 115 days | – |
| Payables Period | 61 days | – |
| Cash Conversion Cycle | 110 days | – |
Income Statement
| Metric | NEOG | NTLA |
|---|---|---|
| Total Revenue | $884M | $60M |
| Operating Income | -$7M | -$423M |
| Net Income | -$52M | -$400M |
| R&D Expense | $20M | $347M |
| SG&A Expense | $430M | – |
| Cost of Goods Sold | $465M | – |
Dividend & Shareholder Information
| Metric | NEOG | NTLA |
|---|---|---|
| Shares Outstanding | 218M | 140M |
NEOG vs NTLA: stock comparison and AI forecast
Which is bigger, NEOG or NTLA?
NEOG is 1.5 times larger than NTLA by market capitalization ($2.58B against $1.75B).
Which one does Intratio's AI model rank higher, NEOG or NTLA?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.